Condition
ATRT Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 2 ATRT Recurrent clinical trials that are recruiting, at sites in 8 countries (most in United States (2), Austria (1), Czechia (1)). By phase: Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 8Countries
All recruiting trials (2)
-
TP53 gene therapy (SGT-53) with nivolumab and focused radiation for children with recurrent brain tumors
This study tests a TP53 gene therapy called SGT-53 combined with the immune drug nivolumab and focused radiation in children whose brain tumors have come back, grown, or not responded to prior treatment.
-
New treatment for children with recurrent brain tumors
This study is testing a new treatment combining an intravenous drug with five oral medications to see if it can help children with recurring brain tumors live longer and feel better.
Related topics
Quick answers
How many ATRT Recurrent clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (2 trials), Austria (1 trial), Czechia (1 trial), Denmark (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.